57 Results

People

  1. Chiosis
    Chiosis
  2. Scheinberg
    Scheinberg
  3. Landgren
    Landgren
  4. Palomba
    Palomba
  5. Mcdevitt
    Mcdevitt
  6. Thompson
    Thompson
  7. Caron
    Caron
  8. Finn
    Finn
  9. Hsu
    Hsu
  10. Noy
    Noy

Groups

  1. Center for Hematologic Malignancies (57)
  2. Hematologic Malignancies Research (57)
  3. GSK Faculty (49)
  4. Sloan Kettering Institute Faculty (39)
  5. Department of Medicine (34)
  6. Molecular Pharmacology and Chemistry Program Faculty (30)
  7. Hematologic Malignancies, Division of (29)
  8. Sloan Kettering Institute Postdocs (18)
  9. Tow Center for Developmental Oncology (TCDO) (18)
  10. Adult Leukemia (15)
  1. "Hematologic Malignancies Research"
  2. "Wiley Blackwell"
Formats
  1. Journal Article (26)
  2. Meeting Abstract (24)
  3. Review (3)
  4. Book Section (2)
  5. Conference Paper (2)
Groups
  1. Center for Hematologic Malignancies (57)
  2. Hematologic Malignancies Research (57)
  3. GSK Faculty (49)
  4. Sloan Kettering Institute Faculty (39)
  5. Department of Medicine (34)
  6. Molecular Pharmacology and Chemistry Program Faculty (30)

More Groups

People
  1. David Scheinberg (10)
  2. Gabriela Chiosis (10)
  3. Carl Landgren (7)
  4. Maria Palomba (6)
  5. Craig Thompson (5)
  6. Michael Mcdevitt (5)

More People

Years
  1. 2023 (9)
  2. 2022 (2)
  3. 2021 (2)
  4. 2020 (2)
  5. 2019 (4)
  6. 2018 (5)

More Years

Publications
  1. Hematological Oncology (9)
  2. Journal of Labelled Compounds and Radiopharmaceuticals (8)
  3. Cancer (5)
  4. EMBO Journal (5)
  5. Immunological Reviews (5)
  6. HLA (3)

More Publications

Publishers
  1. Wiley Blackwell (57)

Results (57)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Challenges and solutions for therapeutic TCR-based agents
    Review

    Malviya, M.; Aretz, Z. E. H.; Molvi, Z.; Lee, J.; Pierre, S.; Wallisch, P.; Dao, T.; Scheinberg, D. A.
    Immunological Reviews (2023)

    Fulltext@MSK | Save
  • Targeting abnormal chaperone activity in a mouse model of synucleinopathy to mitigate cognitive deficits
    Meeting Abstract

    Sandoval, R.; Novikov, V.; Attaran, A.; Durcan, T. M.; Fon, E. A.; Menon, R. S.; Everling, S.; Chiosis, G.; Bussey, T. J.; Saksida, L. M.; more...
    Journal of Neurochemistry (2023)

    Fulltext@MSK | Save
  • SETD1A function in leukemia is mediated through interaction with mitotic regulators BuGZ/BUB3
    Journal Article

    Perlee, S.; Kikuchi, S.; Nakadai, T.; Masuda, T.; Ohtsuki, S.; Matsumoto, M.; Rahmutulla, B.; Fukuyo, M.; Cifani, P.; Kentsis, A.; more...
    EMBO Reports (2023)

    Fulltext@MSK | Save
  • A phase I study of CD19‐targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory diffuse large B‐cell lymphoma
    Meeting Abstract

    Palomba, M. L.; Riviere, I.; Sikder, D. S.; Senechal, B.; Wang, X.; Cathcart, E. R.; Liotta, K.; Li, J.; Sellner, L.; Sadelain, M.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
    Meeting Abstract

    Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Enhancing T‐cell responses to GCB‐like lymphomas with immune‐checkpoint‐blockade‐based therapies
    Meeting Abstract

    Serganova, I.; Bucktrout, R.; Isshiki, Y.; Sarapulov, A.; Santella, A.; Rodriguez, M.; Chakraborty, S.; Brunschvig, S.; Qualls, D.; Vardhana, S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of nivolumab plus adriamycin, vinblastine, dacarbazine (N‐AVD) as frontline therapy in older adults with Hodgkin lymphoma
    Meeting Abstract

    Torka, P.; Feldman, T.; Savage, K.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma: A phase 1/2 study
    Journal Article

    Lesokhin, A.; LeBlanc, R.; Dimopoulos, M. A.; Capra, M.; Carlo-Stella, C.; Karlin, L.; Castilloux, J. F.; Forsberg, P.; Parmar, G.; Tosikyan, A.; more...
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • Epichaperomes as a gateway to understanding, diagnosing, and treating disease through rebalancing protein-protein interaction networks
    Book Section

    Digwal, C. S.; Sharma, S.; Santhaseela, A. R.; Ginsberg, S. D.; Chiosis, G.
    In Kostic, M.; Jones, L. H. (Eds.) Protein Homeostasis in Drug Discovery: A Chemical Biology Perspective (2023)

    Fulltext@MSK | Save
  • Crystal structure of SARS-CoV-2 nsp10–nsp16 in complex with small molecule inhibitors, SS148 and WZ16
    Journal Article

    Klima, M.; Khalili Yazdi, A.; Li, F.; Chau, I.; Hajian, T.; Bolotokova, A.; Kaniskan, H. Ü; Han, Y.; Wang, K.; Li, D.; more...
    Protein Science (2022)

    Fulltext@MSK | Save